Clinical ovarian cancer & other gynecologic malignancies.
- Published in:
- 2010
- Publication type:
- Journal Article
Works matching IS 19414390 AND DT 2010 AND VI 3 AND IP 1
Results: 17
1
2
Coexistent Uterine Choriocarcinoma and Carcinosarcoma With Lung Metastases.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
3
DNA repair-based mechanisms of platinum resistance in epithelial ovarian cancer: from bench to bedside.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
The 41st Annual Meeting on Women's Cancer conducted by the Society of Gynecologic Oncologists, San Francisco, CA, March 14-17, 2010.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
Debate: Paclitaxel plus carboplatin as systemic therapy for endometrial cancers.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
6
Clinical Ovarian Cancer.
- Published in:
- 2010
- By:
- Publication type:
- Table of Contents
7
Do Patients With Platinum-Resistant Epithelial Ovarian Cancer Benefit From Second-line Chemotherapy?
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 1, p. 36, doi. 10.3816/COC.2010.n.006
- By:
- Publication type:
- Article
8
Weekly Administration of Paclitaxel and Carboplatin in the Treatment of Advanced Ovarian or Peritoneal Cancers With Poor Performance Status.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
9
Secondary Debulking Including Nephrectomy in Recurrent Uterine Carcinosarcoma: A Case Report.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
10
Nutritional Intervention in Ovarian Cancer: Failure to Appreciate the Fundamental Distinction Between a Prognostic and a Predictive Clinical Parameter.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
11
DNA Repair–Based Mechanisms of Platinum Resistance in Epithelial Ovarian Cancer: From Bench to Bedside.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 1, p. 29, doi. 10.3816/COC.2010.n.005
- By:
- Publication type:
- Article
12
The 41st Annual Meeting on Women's Cancer Conducted by the Society of Gynecologic Oncologists.
- Published in:
- 2010
- By:
- Publication type:
- Conference Paper/Materials
13
Lysophosphatidic Acid in Patients With Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 1, p. 41, doi. 10.3816/COC.2010.n.007
- By:
- Publication type:
- Article
14
Debate: Paclitaxel Plus Carboplatin as Systemic Therapy for Endometrial Cancers.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 1, p. 21, doi. 10.3816/COC.2010.n.004
- By:
- Publication type:
- Article
15
Selected Trials in Gynecologic Cancer; Currently Open for Enrollment in the United States.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 1, p. 62, doi. 10.3816/COC.2010.n.012
- By:
- Publication type:
- Article
16
Debate: Cisplatin Plus Paclitaxel in the Treatment of Patients With Metastatic/Recurrent Cervical Cancer.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 1, p. 14, doi. 10.3816/COC.2010.n.003
- By:
- Publication type:
- Article
17
The Clinical Impact of Computed Tomography Immediately Following Primary Chemotherapy in Patients With Epithelial Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 1, p. 52, doi. 10.3816/COC.2010.n.009
- By:
- Publication type:
- Article